Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University of Ottawa Opens Social Sciences Building
The University of Ottawa opened its $120 million social sciences facility in fall of 2012. Designed by Diamond Schmitt Architects, the 15-story project is an expansion of the existing Vanier Hall and includes 277,700 sf of new construction and 145,000 sf of renovation. The collaborative building provides research space for neuroscience, economics, experimental psychology, management, and public policy. The facility features a 225-seat tiered lecture hall, a 120-seat classroom, a multistory atrium, and a green roof.
Eli Lilly Expands Pharmaceutical Manufacturing Campus
Eli Lilly will begin construction in late 2012 on a $140 million expansion of its Indianapolis pharmaceutical manufacturing campus. The 80,000-sf addition will support the production of insulin cartridges. Completion is expected in March of 2014 with operations beginning in 2015.
Louisiana Tech Dedicates College of Business
Louisiana Tech dedicated the 42,000-sf College of Business in November of 2012 in Ruston. The $12.5 million facility houses classrooms, teaching labs, research centers, offices, computer labs, conference rooms, and auditoriums. The technology-rich facility was designed by Yeager, Watson and Associates and features a digital forensics lab and video boards displaying business news and stock market information. Ground was broken on the project in February of 2011.
University of Hawaii Builds Cancer Research Center
The University of Hawaii at Manoa is building the $103 million Cancer Research Center in Honolulu. Designed by Shimokawa Nakamura in partnership with ZGF Architects and Jacobs Consultancy, the five-story, 150,000-sf facility will provide advanced biomedical research laboratories and offices. The lead contractor is A.C. Kobayashi Construction of Honolulu. Ground was broken on the project in October of 2010 and occupancy is expected in February of 2013.
Novartis Builds Singapore Biomanufacturing Facility
Novartis will invest $500 million to construct a cell-based biomanufacturing facility in Singapore. Located adjacent to its existing pharmaceutical plant in Tuas, the new biologics center will support both clinical and commercial production of biological therapies such as monoclonal antibodies. Construction will begin in early 2013 with full operations commencing in late 2016.